Beta Amyloid News and Research

RSS

Blood oxygen levels may explain why memory loss is an early symptom of Alzheimer's disease

In a world first, scientists from the University of Sussex have recorded blood oxygen levels in the hippocampus and provided experimental proof for why the area, commonly referred to as 'the brain's memory center', is vulnerable to damage and degeneration, a precursor to Alzheimer's disease.

29 May 2021

Combination of easily accessible tests can enable early, reliable diagnosis of Alzheimer's disease

Researchers at Lund University in Sweden have developed an algorithm that combines data from a simple blood test and brief memory tests, to predict with great accuracy who will develop Alzheimer's disease in the future.

25 May 2021

Study may lead to new treatments for a wide range of neurological conditions

New research published today sheds important light on how the production of a key protein in the brain is controlled, which could pave the way for new treatments for a wide range of neurological conditions.

19 May 2021

Retinal scans may provide an early sign of Alzheimer's disease

While it has been said that the eyes are a window to the soul, a new study shows they could be a means for understanding diseases of the brain.

17 May 2021

Researchers provide a promising new way to elucidate the brain's health

Researchers from the Center for BrainHealth at The University of Texas at Dallas are investigating a potential new early indicator of the decline toward Alzheimer's disease: measuring the energy metabolism of the living human brain using cutting-edge imaging techniques.

4 May 2021

Inhibition of Meprin Β enzyme can trigger the development of Alzheimer's disease, cancer

Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma protein fetuin-B binds to the enzyme meprin β and used a computer model to visualize their findings.

21 Apr 2021

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

A new study, released as a preprint on the bioRxiv* server, casts some light on the pathogenesis of acute and subacute neurological complications associated with COVID-19.

19 Apr 2021

CBD ameliorates cognitive function in experimental model of familial Alzheimer's

A two-week course of high doses of CBD helps restore the function of two proteins key to reducing the accumulation of beta-amyloid plaque, a hallmark of Alzheimer's disease, and improves cognition in an experimental model of early onset familial Alzheimer's, investigators report.

9 Mar 2021

The Role of D-Amino Acids in Humans

In this interview, Dr. Daniel Armstrong from the University of Texas at Arlington talks to News-Medical Life Sciences about his upcoming Pittcon presentation.

From Pittcon 4 Mar 2021

Brain protein responsible for causing Alzheimer's disease also plays a protective role

Findings from a new study on Alzheimer's disease (AD), led by researchers at the University of Saskatchewan, could eventually help clinicians identify people at highest risk for developing the irreversible, progressive brain disorder and pave the way for treatments that slow or prevent its onset.

8 Feb 2021

NeuroVision Imaging receives ADDF funding to develop biomarker tests for Alzheimer's disease

NeuroVision Imaging Inc., announced today it has received an investment from the Alzheimer's Drug Discovery Foundation to support developing reliable, affordable biomarker tests for Alzheimer's disease and other forms of dementia and neurodegenerative disorders.

3 Feb 2021

Study shows link between early brainstem tau accumulation and cortical hyperexcitability

Study conducted by researchers from the GIGA CRC In vivo Imaging laboratory at ULiège demonstrates, for the first time in humans, how the first deposits of tau proteins in the brainstem are associated with neurophysiological processes specific to the early stages of Alzheimer's disease development.

25 Jan 2021

Mice study identifies action mechanism of a promising drug against Alzheimer's disease

A study conducted on mice published in the journal Geroscience has identified the action mechanism of a promising compound against Alzheimer's disease, developed by the team of Medical Chemistry and Pharmacology at the University of Barcelona.

9 Dec 2020

Biochemical cascade in the brain leads to the destruction of synapses in Alzheimer's

A new study on Alzheimer's disease by Scripps Research scientists has revealed a previously unknown biochemical cascade in the brain that leads to the destruction of synapses, the connections between nerve cells that are responsible for memory and cognition.

5 Dec 2020

Alzheimer's study shows tau protein changes according to dementia stage

Research into Alzheimer's disease has long focused on understanding the role of two key proteins, beta amyloid and the tau protein. Found in tangles in patients' brain tissue, a pathological form of the tau protein contributes to propagating the disease in the brain.

19 Nov 2020

Beta Amyloid News and Research

Blood oxygen levels may explain why memory loss is an early symptom of Alzheimer's disease

Combination of easily accessible tests can enable early, reliable diagnosis of Alzheimer's disease

Study may lead to new treatments for a wide range of neurological conditions

Retinal scans may provide an early sign of Alzheimer's disease

Researchers provide a promising new way to elucidate the brain's health

Inhibition of Meprin Β enzyme can trigger the development of Alzheimer's disease, cancer

SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

CBD ameliorates cognitive function in experimental model of familial Alzheimer's

The Role of D-Amino Acids in Humans

Brain protein responsible for causing Alzheimer's disease also plays a protective role

NeuroVision Imaging receives ADDF funding to develop biomarker tests for Alzheimer's disease

Study shows link between early brainstem tau accumulation and cortical hyperexcitability

Mice study identifies action mechanism of a promising drug against Alzheimer's disease

Biochemical cascade in the brain leads to the destruction of synapses in Alzheimer's

Alzheimer's study shows tau protein changes according to dementia stage

Study sheds new light on how diabetes contributes to the development of Alzheimer’s disease

Fatal chain reaction in Alzheimer's disease starts much earlier than commonly assumed

Affinity-Bead Assisted Mass Spectrometry for Proteomics

Severe obstructive sleep apnea linked to increased risk of dementia

The road to achieving single molecular spectroscopy using nanoIR

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News